The Latest Breaking News from FDA

Check your cabinets: White rice recalled in 13 states

FDA issued an update to the recall

The Independent UK · Aug 30

Federal Officials Close the Infant Formula Botulism Investigation After Four Babies Were Hospitalized in Three States

CDC closed the Nara Organics infant botulism investigation with four hospitalized babies and named a supplier link to a 2025 formula outbreak.

Medical Daily · Aug 30

Cyclospora Outbreak Tied to Recalled Lettuce Adds Georgia, Tennessee, and Texas as Confirmed Illnesses Reach 11,458

CDC added Georgia, Tennessee, and Texas to the Taylor Farms lettuce Cyclospora outbreak, now at 11,458 illnesses and 495 hospitalizations.

Medical Daily · Aug 30

A Generic Ivermectin Just Became the Fourteenth Emergency Screwworm Drug, and Supply Concentration Is the Reason Why

The FDA authorized a generic ivermectin injection for New World screwworm, citing the risk of producers becoming dependent on a single manufacturer.

Medical Daily · Aug 29

Baxter Recalls Three Intravenous Solutions on the Same Day Over Fiberglass and Stainless Steel Particle Concerns

Baxter recalled three IV solutions due to possible fiberglass and stainless steel particles. Here are the lots, the states, and who is affected.

Medical Daily · Aug 28

A Lung Cancer Drug Triggered Pancreatitis That Her CT Scan Could Not See

Her pancreatic enzymes were sky-high, and her scans were clean. Doctors traced it to afatinib, weeks after US generics reached the market.

Medical Daily · Aug 28

Nineteen Operating Tables Recalled Over a Lock Failure That Could Let a Patient Shift During Surgery

The FDA issued recalls for IMRIS ORT200 and ORT300 operating tables due to a rotational lock fault. Surgeons are told to test tables daily.

Medical Daily · Aug 28

Juul gets OK to sell updated vaping device with age-gating technology

E-cigarette maker Juul Labs has received U.S. permission to sell an updated version of its vaping device

The Independent UK · Aug 28

Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefit

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes and weight management. The drug demonstrated an 8% greater reduction in cardiovascular events in a key study. Mounjaro's approval strengthens Eli Lilly's position in the GLP-1 medicine market. This…

The Economic Times · Aug 28

The FDA just approved this year’s Covid vaccines - here’s what you need to know about the shots

The vaccines are expected to roll out at hospitals and pharmacies in just days

The Independent UK · Aug 28